Researched and Written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Retired Pharmacist, and Founder of Prevail Over Cancer
Coffee appears to have some significant cancer-fighting benefits.đđđ According to đmedical research, coffee is associated with a reduced risk of cancer. Thereâs even a study that found higher coffee consumption is associated with reduced mortality from colorectal cancer.
Several compounds found in coffee possess antioxidant, anti-inflammatory, and insulin-sensitizing effects, which may contribute to anticancer activity.
In most studies, 3 âď¸âď¸âď¸ or more cups daily provide better protection than 1 cup daily. If you are sensitive to caffeine, you may have to limit your consumption, dilute the coffee, drink early in the day, or switch to naturally decaffeinated. Naturally decaffeinated coffee will not have as many beneficial anti-cancer ingredients.Â
Tea is one of the most widely consumed beverages in the worldâand one of the most researched. Green tea, matcha, and black tea all come from the Camellia sinensis plant, yet each offers unique anticancer benefits thanks to differences in processing, polyphenol content, and antioxidant potency.
For people with cancer and caregivers looking for simple, daily habits that support an anticancer lifestyle, tea is a powerful, evidence-supported place to start.
Tea is rich in polyphenols, plant compounds that help protect cells from oxidative stress, inflammation, and DNA damageâthree biological processes closely linked to cancer development.
The most studied polyphenols include:
What Is Modified Citrus Pectin?
Modified citrus pectin (MCP) is a form of pectin derived from the peel and pulp of citrus fruits. Unlike regular pectinâwhich is too large to be absorbedâMCP is processed into smaller, lowâmolecularâweight fragments that the body can absorb more easily.
MCP is rich in galactoside residues, which give it a unique ability to bind to certain proteins involved in cancer biology, especially galectinâ3.
Â
How MCP May Influence Cancer Biology
Much of MCPâs anticancer interest comes from its ability to bind and block galectinâ3, a protein involved in:
Galectinâ3 is overexpressed in many cancers and is associated with more aggressive dis...